4
Changes in Ownership
KALA BIO, Inc. Filed Acc 0001179110-17-010599
Options or other derivatives
- Chief Scientific Officer acquired 28,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Chen Hongming · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-07-19 | Grant or award : show line 1 in the form Stock Option (right to buy) | +28,800 | $15.00 | 2027-07-18 | 28,800 | 28,800 | D |
Loading xslF345X03/edgar.xml…